Rationale for the use of statins in liver disease.

Schierwagen, Robert; Uschner, Frank Erhard; Magdaleno, Fernando; Klein, Sabine; Trebicka, Jonel

Schierwagen, Robert; Uschner, Frank Erhard; Magdaleno, Fernando; Klein, Sabine; Trebicka, Jonel.

Afiliação

Schierwagen R; Department of Internal Medicine I, University of Bonn, Germany.
Uschner FE; Department of Internal Medicine I, University of Bonn, Germany.
Magdaleno F; Department of Internal Medicine I, University of Bonn, Germany.
Klein S; Department of Internal Medicine I, University of Bonn, Germany.
Trebicka J; Department of Internal Medicine I, University of Bonn, Germany; jonel.trebicka@efclif.com.

Am J Physiol Gastrointest Liver Physiol ; 312(5): G407-G412, 2017 May 01.

Article em En | MEDLINE | ID: mdl-28280144

Assuntos

Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico; Hepatopatias/tratamento farmacológico; Animais; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hepatopatias Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google